Effective regional therapy of experimental cancer with paralesional administration of tumour necrosis factor-α + interferon-γ

This publication has 17 references indexed in Scilit:

• Augmentation by Tumor Necrosis Factor α of the Systemic Therapeutic Effect of Lymphokine-activated Killer Cells in Adoptive Immunotherapy of Murine Tumor
  Japanese Journal of Cancer Research, 1991
• Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes
  Cell, 1989
• Phase I study of intratumoral application of recombinant human tumor necrosis factor
  European Journal of Cancer and Clinical Oncology, 1989
• Intralesional application of recombinant human tumor necrosis factor alpha induces local tumor regression in patients with advanced malignancies
  European Journal of Cancer and Clinical Oncology, 1989
• Induction of Dermal Subcutaneous Inflammation by Recombinant Cachectin/Tumor Necrosis Factor (TNFα) in the Mouse
  Journal of Investigative Dermatology, 1988
• Interferon‐γ and tumor necrosis factor induce the L‐arginine‐dependent cytotoxic effector mechanism in murine macrophages^*
  European Journal of Immunology, 1988
• Lymphocyte function-associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells.
  The Journal of cell biology, 1988
• Regulation of tumor necrosis factor (TNF) expression: Interferon-γ enhances the accumulation of mRNA for TNF induced by lipopolysaccharide in murine peritoneal macrophages
  Cellular Immunology, 1987
• DNA fragmentation and cytotoxicity caused by tumor necrosis factor is enhanced by interferon‐γ
  European Journal of Immunology, 1987
• Recombinant tumor necrosis factor: Species specificity for a variety of human and murine transformed cell lines
  Cellular Immunology, 1986